PubRank

Eric Santoni-Rugiu

Author PubWeight™ 24.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res 2011 1.26
2 Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol 2004 1.25
3 Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regeneration. Hepatology 2007 1.20
4 Lipocalin 2 is protective against E. coli pneumonia. Respir Res 2010 1.19
5 Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene. Oncogene 2004 1.09
6 Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1. Am J Pathol 2002 1.07
7 Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report. BMC Res Notes 2013 1.06
8 Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinoma. Int J Cancer 2011 0.99
9 Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS. Oncogene 2005 0.96
10 The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer 2011 0.96
11 Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial. Clin Cancer Res 2011 0.94
12 MMSET is highly expressed and associated with aggressiveness in neuroblastoma. Cancer Res 2011 0.93
13 Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice. PLoS Genet 2013 0.91
14 No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer. PLoS One 2012 0.90
15 Personalized oncology: genomic screening in phase 1. APMIS 2014 0.89
16 Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival. J Thorac Oncol 2012 0.85
17 ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial. Eur J Cancer 2010 0.85
18 Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma. J Thorac Oncol 2013 0.84
19 A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma. Cancer Chemother Pharmacol 2012 0.83
20 Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma? APMIS 2012 0.79
21 Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma. Int J Cancer 2011 0.79
22 The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas. Histopathology 2012 0.79
23 Safety pharmacology, toxicology and pharmacokinetic assessment of human Gc globulin (vitamin D binding protein). Basic Clin Pharmacol Toxicol 2010 0.77
24 Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients. Cancer Chemother Pharmacol 2013 0.76
25 Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer. Histopathology 2013 0.76
26 Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer. J Cancer Res Clin Oncol 2014 0.76
27 Ossifying thymoma associated with refractory myasthenia gravis. APMIS 2010 0.75
28 Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer. Cancer Chemother Pharmacol 2013 0.75
29 [In Process Citation]. Ugeskr Laeger 2015 0.75
30 [Lack of uniformity in the treatment of thymomas]. Ugeskr Laeger 2012 0.75
31 Molecular imaging in Libman-Sacks endocarditis. Infect Dis (Lond) 2015 0.75